- Home /
- Submissions
Submissions
Author Guidelines
Journal of Indo-Pacific Academy of Forensic Odontology
ISSN: 2231-1092 EISSN:2231-1572
SUBMISSION DETAILS
Submission of manuscripts
All manuscripts should be submitted to the Editor, JINPAFO by email to the id: inpafojournal@gmail.com. All manuscripts should be sent in MS Word files. No zip files should be sent.
The manuscript should be sent in separate files for the following:
1. Title page:
It should state -
a) The type of manuscript - Original Article/ Case Report/ Review Article/ Letter to the Editor, etc.
b) Title of the manuscript, names & mailing address of all the authors in the order that these should appear along with designations, names of the department & institution.
2. Article file:
The manuscript must not contain any mention of the author's name or initials or the institution in which the said study was done. The main text of the article from the abstract to the references should be in this file. Do not include any tables/ images/ graphs in this file. Just mention their number.
3. Tables/ graphs/ images:
· Submit tables, graphs, and images as separate files (not embedded within the main text).
· Image quality: Must be clear, high-resolution, and preferably 300 dpi or higher.
· File size: Each image should be ≤ 5 MB.
· File format: JPG/JPEG formats are acceptable.
· Legends: Provide figure and image legends within the main manuscript text, not within the image file.
Copy Right Transfer Form
This must be submitted in original with the signatures of all the contributors. It can be sent by post or as a scanned copy via email.
Conflict of Interest
All authors must declare any conflict of interest they have with the publication of the manuscript or an Institution or a product that is mentioned in the article.
All the authors should also give a certificate to the effect that the manuscript has been read and approved by all and that all of them agree with the ranking of the authorship. The certificate should also state that the work done which is being published through the said manuscript is their original and honest work.
Preparation of Manuscripts
Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals ("often known as the "Vancouver system"). The uniform requirements and specific requirement of the JINPAFO are summarized below. JINPAFO accepts manuscripts written in English.
Copies of any permission(s)
It is the responsibility of authors/contributors to obtain permission for reproducing any copyrighted material.
Types of manuscript
All manuscript types must include a structured abstract not exceeding 250 words and 3–5 keywords.
Original article: These include randomized controlled trials, outcome studies, cost effectiveness analyses, case- control series and surveys with high response rate. The text of original articles amounting to up to 2000 words (excluding abstract, references and tables) should be divided into sections with the headings Abstract, Keywords, Introduction, Material and Methods, Results, Discussion, References, Tables, and Figure Legends.
Introduction: State the purpose and summarize the rationale for the study or observation.
Material & Methods: It should include and describe the following aspects:
Ethics: A statement of the Ethics Committee Permission must be included in all research articles under the "Materials and Methods" section. Ensure the confidentiality of subjects by desisting from mentioning participant's names, initials or hospital numbers, especially in illustrative material. Authors should remove patients' names/ identifying features from figures unless they have obtained written informed consent from the patients. When informed consent has been obtained, it should be indicated in the article and a copy of the consent should be attached to the cover letter. The journal will not consider any paper which is ethically unacceptable.
Study design: The study design should be described in detail using standard methodological terms such as retrospective or prospective cohort study, case-control study, etc. Describe your selection of the observational or experimental participants clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Statistical methods used for analyzing data should be described in detail. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'.
Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Restrict tables and figures to those needed to explain the argument and assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Extra or supplementary materials and technical details can be placed in an appendix which will be accessible but will not interrupt the flow of the text.
Discussion: Include a summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); strengths and limitations of the study (study question, study design, data collection, analysis, and interpretation); Interpretation and implications in the context of the totality of the evidence. What this study adds to the available evidence, effects on patient care and health policy, controversies raised by this study, a future research direction. Statements/ conclusions for which adequate data has not been obtained should be avoided, contributors should avoid making statements on economic benefits and costs unless their manuscript economic data and analyses. New hypotheses may be stated if needed, however, they should be clearly labeled as such. About 30 references can be included.
Review Articles
It is expected that these articles would be written by authorities who have done substantial work on the subject or are considered experts in the field. The prescribed word count is up to 2500 words (excluding tables, references, and abstracts). The manuscript should have an unstructured Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review articles should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.
Case Reports
New interesting and rare cases can be reported. They should be unique, describing a medical challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Keywords, Introduction, Case report, Discussion, Reference, Tables and Legends in that order. The case reports could be supported with up to 10 references. Case Reports could be authored by up to four authors.
Letter to the Editor
These should be concise and decisive observations. They should preferably be related to articles previously published in the journal or views expressed in the journal. They should not be preliminary observations that need a later paper for validation. The letter could have up to 300 words and 5 references. It could be generally authored by not more than three authors.
Other
Editorial, Guest Editorial, and Commentary are solicited by the Editorial Board.
References
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in the text, tables, and legends by Arabic numerals in brackets [], just after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use the complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing "personal communication" with written permission from the source. Avoid citing "Personal communications" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.
The commonly cited types of references are shown here, for other types of references such as newspaper items please refer to ICMJE Guidelines (http://www.icmie.org or http://www.nlm.nih.gov/bsd/ uniform_requirements.html)
Standard Journal Article
· If less than six authors, list all the authors.
Halpern SD, Ubel PA, Caplan AL, Solid-organ transplantation in HIV - infected patients. N Engl J Med. 2002; 347:254-7
· If more than six authors, list the first six authors followed by et al.
Rose ME, Huerbin MB, Melick l, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935: 40-6
Books and other monographs
· Personal author(s)
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA, Medical Microbiology. 4th ed. SI.Louia: Mosby; 2002
· Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM, Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002.p. 93-113.
Sending a revised manuscript
The revised version of the manuscript should be submitted online in a manner like that used for the submission of the manuscript for the first time. However, there is no need to submit the "First Page" or "Covering Letter" file which submitting a revised version. When submitting a revised manuscript, contributors are requested to include the 'referees' remarks along with point-to-point clarification at the beginning of the revised fire itself. In addition, they are expected to mark the changes as underlined or colored text in the article.
Proofs
Proofs will be sent to the corresponding authors by email approximately 2 weeks before the publication date.
Copyrights
The entire contents of the Journal of INPAFO are protected under Indian and International copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to and a license to copy, use, distribute, perform, and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and owner ship of the rights.
Submission Preparation Checklist
All submissions must meet the following requirements.
- This submission meets the requirements outlined in the Author Guidelines.
- This submission has not been previously published, nor is it before another journal for consideration.
- All references have been checked for accuracy and completeness.
- All tables and figures have been numbered and labeled.
- Permission has been obtained to publish all photos, datasets and other material provided with this submission.
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.